Search clinical trials for: ABVD

Total 78 results

Shandong Provincial Hospital

Unknown

Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

Lymphoma, Non-Hodgkin;Hodgkin Disease

China
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) (HD0803)

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients (HD0801)

Hodgkin's Lymphoma

Italy
Centre Hospitalier Universitaire Dijon
The Lymphoma Study Association

Completed

Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL (AHL 2011)

Hodgkin's Lymphoma

France, Belgium
Gruppo Italiano Studio Linfomi

Completed

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) (HD2000)

Advanced Hodgkin Disease

Italy
Fondazione Italiana Linfomi ONLUS

Completed

Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma

Hodgkin Lymphoma

Italy
University Hospital, Grenoble
French Innovative Leukemia Organisation

Completed

Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma (LTP)

Peripheral T Cell Lymphoma

France
University Hospital Carl Gustav Carus
Technische Universität Dresden

Unknown

Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET

Hodgkin Disease

Germany
European Organisation for Research and Treatment...
Polish Lymphoma Research Group

Withdrawn

Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) (H11)

Hodgkin Lymphoma

Denmark
Weill Medical College of Cornell University

Terminated

Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States
Hospital JP Garrahan
Hospital Pereyra Rosell, Montevideo, Uruguay

Recruiting

Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation. (LHGALOP2017)

Pediatric Hodgkin's Disease

Argentina
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Lymphoma

United States
Sheba Medical Center

Unknown

Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers

Type I Diabetes Mellitus With Ulcer | Type II Diabetes Mellitus With Ulcer

Israel
University of Modena and Reggio Emilia
Millennium Pharmaceuticals, Inc.

Unknown

Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma

Hodgkin Lymphoma

Italy
Sun Yat-sen University

Not yet recruiting

Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

Classic Hodgkin Lymphoma
Aviceda Therapeutics, Inc.

Terminated

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

United States
University of Aarhus

Completed

Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection (FACIT)

Clostridium Difficile Infection

Denmark
Lee's Pharmaceutical Limited

Unknown

Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol

Advanced Hodgkin's Lymphoma
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
BioMed Valley Discoveries, Inc

Completed

Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers

Healthy
Aviceda Therapeutics, Inc.

Recruiting

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (SIGLEC)

Macular Degeneration | Geographic Atrophy of the Macula

United States
BioMed Valley Discoveries, Inc

Completed

Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies

Advanced Solid Tumors

United States
BioMed Valley Discoveries, Inc

Completed

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
BioMed Valley Discoveries, Inc

Terminated

Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations

Advanced Solid Tumor | MAP2K1 Gene Mutation | BRAF Gene Mutation | MEK Mutation | BRAF Gene Alteration | MEK Alteration | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene Alteration

United States
University of Pittsburgh

Withdrawn

Short Atrioventricular Delay Pacing (SAVD)

Chronically (i.e. Implanted for at Least Six Months) Dual-chamber Pacemaker | Stable Cardiac Status (i.e. no Hospitalizations or Cardiac Medication Changes Within 3 Months)

United States
Advanced BioDesign

Active, not recruiting

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients (ODYSSEY)

Myelodysplastic Syndromes | Acute Myeloid Leukemia, Adult

France
Dana-Farber Cancer Institute
BioMed Valley Discoveries, Inc

Active, not recruiting

A Phase II Study of BVD-523 in Metastatic Uveal Melanoma

Uveal Melanoma

United States
xCures
Cancer Commons

Available

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Melanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditions

United States
American Scitech International
Bristol-Myers Squibb; Eli Lilly and Company

Unknown

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States
Indiana University
Purdue University

Recruiting

Effect of Stimulation on the Vagus Nerve

Healthy Subjects

United States
Assiut University

Unknown

Foot Abnormalities in Diabetic CKD Patients

Diabetic Foot | CKD
University of Miami

Completed

Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification

Diagnoses Disease

United States
Prince of Songkla University
National Research Council of Thailand

Unknown

The Safety of Tuberculosis Treatments by Oral Inhalation

Healthy

Thailand
BioFirst Corporation
ABVC BioPharma, Inc

Suspended

Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE)

Retinal Detachment

Thailand, Australia
University of Oslo
Norwegian Institute of Public Health; Norwegian Foundation for Health and Rehabilitation and other collaborators

Completed

Bioavailability of Vitamin D in Cod Liver Oil and Multivitamin Tablets in Healthy Subjects in Norway

Healthy

Norway
National Cancer Institute (NCI)

Active, not recruiting

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditions

United States, Puerto Rico
Tel Aviv University

Completed

ACT With Feedback for Post Traumatic Stress Disorder (PTSD)

PTSD

Israel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China

Invasive Fungal Disease

China
Istanbul Medeniyet University

Completed

Nonpharmacological Methods for Children in Procedural Pain

Procedural Pain | Procedural Anxiety

Turkey
University of Texas Southwestern Medical Center

Not yet recruiting

EGCG for Hepatocellular Carcinoma Chemoprevention (CATCH-B)

Cirrhosis, Liver
LG Chem

Not yet recruiting

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type B Infection
Universidade Federal de Pernambuco

Unknown

Inspiratory Muscle Training Effectiveness in Sympathetic Activity and Functional Capacity in Patients With Heart Failure

Heart Failure

Brazil
Fundacion SEIMC-GESIDA
Abbott

Completed

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (KALIPO)

HIV Infections | HIV Infection

Spain
Peking Union Medical College Hospital

Recruiting

To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD

Invasive Fungal Disease

China
M.D. Anderson Cancer Center
Eli Lilly and Company; BioMed Valley Discoveries, Inc

Recruiting

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Metastatic Colorectal Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Pfizer; BioMed Valley Discoveries, Inc

Recruiting

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Melanoma | Pancreatic Cancer | Tumor, Solid

United States
University College, London
BeiGene

Not yet recruiting

Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma (RATiFY)

Hodgkin Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

Invasive Aspergillosis | Invasive Candidiasis
American Scitech International
Bristol-Myers Squibb; Eli Lilly and Company

Unknown

Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease

Hodgkin's Disease

United States
Merck Sharp & Dohme LLC

Completed

Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) (MODIFY III)

Clostridium Difficile Infection

United States, Argentina, Brazil, Colombia, Czechia, Germany, Hungary, Malaysia, Mexico, Norway, Poland, Portugal, Romania, South Africa, Spain, Sweden, United Kingdom

Search clinical trials for: ABVD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations